Carmat sells its artificial heart for the first time in Italy
Click on this link to read the article from Le Monde
This is the company's first sale since its creation in 2008. The French company Carmat announced on Monday, July 19, that it has commercialized for the first time its total artificial heart, under the brand name Aeson, in Naples. It is implanted in a patient to serve as a relay while waiting for a transplant.
Also to be discovered
Truffle Capital reports outstanding 2020 stock market performance for its listed BioMedTech portfolio companies
Three companies founded or co-founded by Truffle represent 30% of the total valuation of the highest BioMedTech market caps of Euronext Paris...